COMPANY

Advertent Biotherapeutics, Inc.

Advertent Biotherapeutics, Inc. is a privately held biotechnology company. From company website Source · Oct 12, 2026

Keywords: biotechnology

Location: East Lansing, MI · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $750K (SBIR Phase II 5R44AR081168-03, continuation, notice Jul 14, 2026). NIH RePORTER 5R44AR081168-03 (Jul 14, 2026)
Evidence (1 event)
- Jul 14, 2026 · NIH RePORTER 5R44AR081168-03
  Organization: ADVERTENT BIOTHERAPEUTICS, INC.; City/State: EAST LANSING, MI; Project number: 5R44AR081168-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-14; FY total cost (award amount): 750221; Administering IC: National Institute of Arthritis and Musculoskeletal and Skin Diseases; Project title: A novel agent for preventing fatty degeneration of muscles in LGMD2B; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Jul 14, 2026 Grant Government grant — SBIR: $750,221 (annual award, as published), announced Jul 14, 2026. Agency: NIH/NIAMS. Source: government award database. source ↗
Jun 25, 2025 Grant Government grant — SBIR: $1.29M (annual award, as published), announced Jun 25, 2025. Agency: NIH/NIAMS. Source: government award database. source ↗

Last 2 years.

Jul 14, 2026 Government grant — SBIR: $750,221 (annual award, as published), announced Jul 14, 2026. Agency: NIH/NIAMS. Source: government award database. source ↗
Jun 25, 2025 Government grant — SBIR: $1.29M (annual award, as published), announced Jun 25, 2025. Agency: NIH/NIAMS. Source: government award database. source ↗